Fisher & Paykel Healthcare has upgraded its earnings guidance by $5 million for the financial year ended March 31, 2019, due to strong sales and gains from a weakening New Zealand dollar.
Shares in New Zealand’s biggest listed healthcare company gained 2.1%, or 32c, to $15.56, following the
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
